Trials / Unknown
UnknownNCT03011827
Thromboelastometry in Liver Transplantation
Transfusion Prediction Model in Orthotopic Liver Transplantation Based on Thromboelastometry: Prospective Validation Study.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 65 (estimated)
- Sponsor
- Hospital Clinic of Barcelona · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Thromboelastometry better assess coagulation than standard coagulation test in patients undergoing ortothopic liver transplantation. In a post-hoc analysis from a randomized study recently conducted by our group, presurgical values of MA10 Extem \< 35 mm are highly predictive of RBC administration , with no further improvement over MA10 Extem \>40 mm ; suggesting that MA10 Extem between 35-40 would be the optimal range to manage blood product administration. The aim of the study is to validate this result in a prospective cohort of patients submitted to ortothopic liver transplantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fibrinogen and/or platelets administration | Fibrinogen and/or platelets administration to maintain clot amplitude at 10 minutes of the thromboelastometry between 35-40 mm along liver transplant procedure |
Timeline
- Start date
- 2019-08-01
- Primary completion
- 2022-09-01
- Completion
- 2022-10-01
- First posted
- 2017-01-05
- Last updated
- 2019-08-07
Locations
2 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT03011827. Inclusion in this directory is not an endorsement.